Precisely Tuned Inhibition of HIF Prolyl Hydroxylases Is Key for Cardioprotection After Ischemia.

Jatho A., Zieseniss A., Brechtel-Curth K., Yamamoto A., Coleman ML., Vergel Leon AM., Biggs D., Davies B., Pugh CW., Ratcliffe PJ., Katschinski DM.

DOI

10.1161/CIRCRESAHA.120.318216

Type

Journal article

Journal

Circ Res

Publication Date

16/04/2021

Volume

128

Pages

1208 - 1210

Keywords

doxycycline, heart failure, incidence, myocardial infarction, prolyl hydroxylase

Permalink Original publication